CIRCULATING MICRORNAS ASSOCIATED WITH DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Mahon, K. L. [1 ,2 ]
Chiam, K. [2 ]
Lee, B. Y. [2 ]
Nguyen, Q. [2 ]
Boyer, M. J. [1 ]
Stockler, M. [1 ,3 ]
Pavlakis, N. [4 ]
Marx, G. [5 ]
Mallesara, G. [6 ]
Gurney, H. [7 ]
Clark, S. [2 ]
Swarbrick, A. [2 ]
Daly, R. [8 ]
Horvath, Lisa [1 ,2 ]
机构：
[1] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[2] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Div, Sydney, NSW, Australia
[3] NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[4] Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
[5] Sydney Adventist Hosp, Northern Haematol & Oncol Grp, Sydney, NSW, Australia
[6] Calvary Mater Hosp, Newcastle, NSW, Australia
[7] Westmead Hosp, Sydney, NSW, Australia
[8] Monash Univ, Melbourne, Vic 3004, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [21] The roles of microRNAs in the progression of castration-resistant prostate cancer
    Kojima, Satoko
    Goto, Yusuke
    Naya, Yukio
    JOURNAL OF HUMAN GENETICS, 2017, 62 (01) : 25 - 31
  • [22] DOCETAXEL RETREATMENT IN DOCETAXEL-PRETREATED CASTRATION-RESISTANT PROSTATE CANCER
    Di Lorenzo, Giuseppe
    Palmieri, Giovannella
    Buonerba, Carlo
    Marinelli, Alfredo
    De Placido, Sabino
    Altieri, Vincenzo
    Ferro, Matteo
    Mariano, Marsicano
    Vittorino, Montanaro
    Luigi, Castaldo
    Antonio, Tesone
    Modestino, Tronino
    ANTICANCER RESEARCH, 2010, 30 (04) : 1533 - 1533
  • [23] Impact of carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (DRPC) on free testosterone levels.
    Reuter, C. W.
    Morgan, M. A.
    Fenner, M.
    Ivanyi, P.
    Gruenwald, V.
    Ganser, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] SYNERGISTIC ANTITUMOR EFFECT OF NVP-BEZ235 AND SUNITINIB ON DOCETAXEL-RESISTANT HUMAN CASTRATION-RESISTANT PROSTATE CANCER CELLS
    Yoon, Cheol Yong
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A194 - A194
  • [25] Treatment options in advanced castration-resistant, docetaxel-resistant prostate cancer (ACRDRPC). Final results of a network meta-analysis
    Cherubini, C.
    Bianchi, E.
    Tamburini, E.
    Drudi, F.
    Stocchi, L.
    Nicoletti, S. V. L.
    Perini, F.
    Venturi, A.
    Montanari, F.
    Tassinari, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Treament options in advanced castration-resistant, docetaxel-resistant prostate cancer (acrdrpc). final results of a network meta-analysis
    Cherubini, C.
    Bianchi, E.
    Montanari, F.
    Tamburini, E.
    Fantini, M.
    Ridolfi, C.
    Santelmo, C.
    Nicoletti, S. L. V.
    Pasini, G.
    Stocchi, L.
    Tassinari, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Synergistic Antitumor Effect of NVP-BEZ235 and Sunitinib on Docetaxel-resistant Human Castration-resistant Prostate Cancer Cells
    Park, Hong Seok
    Hong, Sung Kyu
    Oh, Mi Mi
    Yoon, Cheol Yong
    Jeong, Seong Jin
    Byun, Seok Soo
    Cheon, Jun
    Lee, Sang Eun
    Moon, Du Geon
    ANTICANCER RESEARCH, 2014, 34 (07) : 3457 - 3468
  • [28] Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
    Marin-Aguilera, Mercedes
    Codony-Servat, Jordi
    Kalko, Susana G.
    Fernandez, Pedro L.
    Bermudo, Raquel
    Buxo, Elvira
    Jose Ribal, Maria
    Gascon, Pedro
    Mellado, Begona
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) : 329 - 339
  • [29] γ-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer
    Onishi, Kenta
    Miyake, Makito
    Hori, Shunta
    Onishi, Sayuri
    Iida, Kota
    Morizawa, Yosuke
    Tatsumi, Yoshihiro
    Nakai, Yasushi
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    ONCOLOGY LETTERS, 2020, 19 (03) : 2306 - 2316
  • [30] Retreatment with docetaxel in metastatic castration-resistant prostate cancer (CRPC).
    Gernone, A.
    Pagliarulo, A.
    Pagliarulo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345